» Articles » PMID: 34440945

Sodium Toxicity in the Nutritional Epidemiology and Nutritional Immunology of COVID-19

Overview
Publisher MDPI
Specialty General Medicine
Date 2021 Aug 27
PMID 34440945
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Dietary factors in the etiology of COVID-19 are understudied. High dietary sodium intake leading to sodium toxicity is associated with comorbid conditions of COVID-19 such as hypertension, kidney disease, stroke, pneumonia, obesity, diabetes, hepatic disease, cardiac arrhythmias, thrombosis, migraine, tinnitus, Bell's palsy, multiple sclerosis, systemic sclerosis, and polycystic ovary syndrome. This article synthesizes evidence from epidemiology, pathophysiology, immunology, and virology literature linking sodium toxicological mechanisms to COVID-19 and SARS-CoV-2 infection. Sodium toxicity is a modifiable disease determinant that impairs the mucociliary clearance of virion aggregates in nasal sinuses of the mucosal immune system, which may lead to SARS-CoV-2 infection and viral sepsis. In addition, sodium toxicity causes pulmonary edema associated with severe acute respiratory syndrome, as well as inflammatory immune responses and other symptoms of COVID-19 such as fever and nasal sinus congestion. Consequently, sodium toxicity potentially mediates the association of COVID-19 pathophysiology with SARS-CoV-2 infection. Sodium dietary intake also increases in the winter, when sodium losses through sweating are reduced, correlating with influenza-like illness outbreaks. Increased SARS-CoV-2 infections in lower socioeconomic classes and among people in government institutions are linked to the consumption of foods highly processed with sodium. Interventions to reduce COVID-19 morbidity and mortality through reduced-sodium diets should be explored further.

Citing Articles

Sodium Starch Glycolate (SSG) from Sago Starch () as a Superdisintegrant: Synthesis and Characterization.

Putra O, Musfiroh I, Elisa S, Musa M, Ikram E, Chaidir C Molecules. 2024; 29(1).

PMID: 38202734 PMC: 10779860. DOI: 10.3390/molecules29010151.


Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat.

Bello I, Omigbodun A, Morhason-Bello I BMC Urol. 2023; 23(1):207.

PMID: 38082261 PMC: 10712029. DOI: 10.1186/s12894-023-01371-x.


Ceragenins exhibit bactericidal properties that are independent of the ionic strength in the environment mimicking cystic fibrosis sputum.

Sklodowski K, Suprewicz L, Chmielewska-Deptula S, Kaliniak S, Okla S, Zakrzewska M Front Microbiol. 2023; 14:1290952.

PMID: 38045035 PMC: 10693459. DOI: 10.3389/fmicb.2023.1290952.


Hypertension, Anxiety and Obstructive Sleep Apnea in Cardiovascular Disease and COVID-19: Mediation by Dietary Salt.

Brown R Diseases. 2022; 10(4).

PMID: 36278588 PMC: 9590013. DOI: 10.3390/diseases10040089.


Non-Specific Low Back Pain, Dietary Salt Intake, and Posterior Lumbar Subcutaneous Edema.

Brown R Int J Environ Res Public Health. 2022; 19(15).

PMID: 35954516 PMC: 9368517. DOI: 10.3390/ijerph19159158.

References
1.
Subramanian A, Anand A, Adderley N, Okoth K, Toulis K, Gokhale K . Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Eur J Endocrinol. 2021; 184(5):637-645. PMC: 8052516. DOI: 10.1530/EJE-20-1163. View

2.
van der Toorn J, Cepeda M, Kiefte-de Jong J, Franco O, Voortman T, Schoufour J . Seasonal variation of diet quality in a large middle-aged and elderly Dutch population-based cohort. Eur J Nutr. 2019; 59(2):493-504. PMC: 7058580. DOI: 10.1007/s00394-019-01918-5. View

3.
Wu J, Song S, Cao H, Li L . Liver diseases in COVID-19: Etiology, treatment and prognosis. World J Gastroenterol. 2020; 26(19):2286-2293. PMC: 7243650. DOI: 10.3748/wjg.v26.i19.2286. View

4.
Sigal C, DOBSON R . The effect of salt intake on sweat gland function. J Invest Dermatol. 1968; 50(6):451-5. DOI: 10.1038/jid.1968.73. View

5.
Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F . Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020; 71(15):896-897. PMC: 7184372. DOI: 10.1093/cid/ciaa415. View